Gilead Sciences, Inc. (0QYQ.IL)
IOB - IOB Delayed price. Currency in USD
Add to watchlist
At close: 04:54PM BST
| Previous close | 66.18 |
| Open | 65.44 |
| Bid | 62.05 x N/A |
| Ask | 68.08 x N/A |
| Day's range | 64.84 - 65.58 |
| 52-week range | 64.74 - 87.53 |
| Volume | |
| Avg. volume | 50,243 |
| Market cap | 81.084B |
| Beta (5Y monthly) | 0.35 |
| PE ratio (TTM) | 14.96 |
| EPS (TTM) | 4.35 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | 3.00 (3.81%) |
| Ex-dividend date | 14 Sept 2023 |
| 1y target est | N/A |
Insider MonkeyGilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript April 25, 2024 Gilead Sciences, Inc. beats earnings expectations. Reported EPS is $-1.32, expectations were $-1.49. Gilead Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, everyone, and […]
ZacksGilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Simply Wall St.Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Gilead Sciences ( NASDAQ:GILD ) First Quarter 2024 Results Key Financial Results Revenue: US$6.69b (up 5.3% from 1Q...
© 2024 Yahoo. All rights reserved.